scholarly journals Interaction betweenPseudomonas aeruginosaandAspergillus fumigatusin cystic fibrosis

PeerJ ◽  
2018 ◽  
Vol 6 ◽  
pp. e5931 ◽  
Author(s):  
Jingming Zhao ◽  
Wencheng Yu

BackgroundCystic fibrosis (CF) is a disease characterized by chronic airway infection with a high incidence and poor prognosis.Pseudomonas aeruginosaandAspergillus fumigatusare pathogens commonly found in CF patients. Clinically, these two microorganisms often coexist in the airway of CF patients. Combined infection withP. aeruginosaandA. fumigatusresults in worsening lung function and clinical condition.MethodsIn this review, we focus on the mutual inhibition and promotion mechanisms ofP. aeruginosaandA. fumigatusin CF patients. We also summarized the mechanisms of the interaction between these pathogenic microorganisms.ResultsP. aeruginosainhibitsA. fumigatusgrowth through the effects of phenazines, the quorum sensing system, iron competition, bacteriophages, and small colony variants.P. aeruginosainducesA. fumigatusgrowth through volatile organic compounds and subbacteriostatic concentrations of phenazines.A. fumigatusinterferes withP. aeruginosa, affecting its metabolic growth via phenazine metabolic transformation, gliotoxin production, and reduced antibiotic sensitivity.DiscussionCoexistence ofP. aeruginosaandA. fumigatuscan lead to both mutual inhibition and promotion. In different stages of CF disease, the interaction between these two pathogenic microorganisms may shift between promotion and inhibition. A discussion of the mechanisms ofP. aeruginosaandA. fumigatusinteraction can be beneficial for further treatment of CF patients and for improving the prognosis of the disease.

2021 ◽  
Author(s):  
Rebekah A. Jones ◽  
Holly Shropshire ◽  
Caimeng Zhao ◽  
Andrew Murphy ◽  
Ian Lidbury ◽  
...  

AbstractPseudomonas aeruginosa is a nosocomial pathogen with a prevalence in immunocompromised individuals and is particularly abundant in the lung microbiome of cystic fibrosis patients. A clinically important adaptation for bacterial pathogens during infection is their ability to survive and proliferate under phosphorus-limited growth conditions. Here, we demonstrate that P. aeruginosa adapts to P-limitation by substituting membrane glycerophospholipids with sugar-containing glycolipids through a lipid renovation pathway involving a phospholipase and two glycosyltransferases. Combining bacterial genetics and multi-omics (proteomics, lipidomics and metatranscriptomic analyses), we show that the surrogate glycolipids monoglucosyldiacylglycerol and glucuronic acid-diacylglycerol are synthesised through the action of a new phospholipase (PA3219) and two glycosyltransferases (PA3218 and PA0842). Comparative genomic analyses revealed that this pathway is strictly conserved in all P. aeruginosa strains isolated from a range of clinical and environmental settings and actively expressed in the metatranscriptome of cystic fibrosis patients. Importantly, this phospholipid-to-glycolipid transition comes with significant ecophysiological consequence in terms of antibiotic sensitivity. Mutants defective in glycolipid synthesis survive poorly when challenged with polymyxin B, a last-resort antibiotic for treating multi-drug resistant P. aeruginosa. Thus, we demonstrate an intriguing link between adaptation to environmental stress (nutrient availability) and antibiotic resistance, mediated through membrane lipid renovation that is an important new facet in our understanding of the ecophysiology of this bacterium in the lung microbiome of cystic fibrosis patients.


PEDIATRICS ◽  
1959 ◽  
Vol 24 (1) ◽  
pp. 40-42
Author(s):  
Fred E. Pittman ◽  
Calderon Howe ◽  
Louise Goode ◽  
Paul A. di Sant'Agnese

In this study, 198 strains of hemolytic, coagulase-positive Staph. aureus were recovered from 84 patients with cystic fibrosis of the pancreas and some of their relatives. The majority of the organisms fell into phage group III and were resistant in vitro to penicillin and other antibiotics. No single phage type seemed to be unduly prevalent in this group of patients with cystic fibrosis of the pancreas.


2000 ◽  
Vol 161 (4) ◽  
pp. 1252-1255 ◽  
Author(s):  
ALAN H. COHEN ◽  
STUART C. SWEET ◽  
ERIC MENDELOFF ◽  
GEORGE B. MALLORY ◽  
CHARLES B. HUDDLESTON ◽  
...  

2020 ◽  
Vol 6 (1) ◽  
pp. 00171-2019 ◽  
Author(s):  
Ronja Weber ◽  
Naemi Haas ◽  
Astghik Baghdasaryan ◽  
Tobias Bruderer ◽  
Demet Inci ◽  
...  

Early pulmonary infection and inflammation result in irreversible lung damage and are major contributors to cystic fibrosis (CF)-related morbidity. An easy to apply and noninvasive assessment for the timely detection of disease-associated complications would be of high value. We aimed to detect volatile organic compound (VOC) breath signatures of children with CF by real-time secondary electrospray ionisation high-resolution mass spectrometry (SESI-HRMS).A total of 101 children, aged 4–18 years (CF=52; healthy controls=49) and comparable for sex, body mass index and lung function were included in this prospective cross-sectional study. Exhaled air was analysed by a SESI-source linked to a high-resolution time-of-flight mass spectrometer. Mass spectra ranging from m/z 50 to 500 were recorded.Out of 3468 m/z features, 171 were significantly different in children with CF (false discovery rate adjusted p-value of 0.05). The predictive ability (CF versus healthy) was assessed by using a support-vector machine classifier and showed an average accuracy (repeated cross-validation) of 72.1% (sensitivity of 77.2% and specificity of 67.7%).This is the first study to assess entire breath profiles of children with SESI-HRMS and to extract sets of VOCs that are associated with CF. We have detected a large set of exhaled molecules that are potentially related to CF, indicating that the molecular breath of children with CF is diverse and informative.


2006 ◽  
Vol 27 (5) ◽  
pp. 929-936 ◽  
Author(s):  
M. Barker ◽  
M. Hengst ◽  
J. Schmid ◽  
H-J. Buers ◽  
B. Mittermaier ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. S122
Author(s):  
T. Goddard ◽  
N. Darmawardana ◽  
R. Yazbek ◽  
J. Martin ◽  
J. Morton ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document